Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Hurwitz

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2010
Radiation therapy induces circulating serum Hsp72 in patients with prostate cancerMark D Hurwitz, Punit Kaur, Ganachari M Nagaraja, et al.
Expert Review of Medical Devices|November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancerNicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Expert Review of Anticancer Therapy|October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysisMark D Hurwitz, Lindsey Schnieder, Judith Manola, et al.
The Medical Journal of Australia|October 22, 2008
A robust clinical review process: the catalyst for clinical governance in an Australian tertiary hospitalImogen A Mitchell, Bobby Antoniou, Judith L Gosper, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2006
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancerClair Beard, Delray Schultz, Marian Loffredo, et al.
Pathology|April 19, 2003
Recent onset granulomatous common variable immunodeficiency in an 88-year-old womanCarolyn A Hawkins, Julie Blasioli, C Siobhan McCarthy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2015
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalationNicholas G Zaorsky, Joshua D Palmer, Mark D Hurwitz, et al.
Urology|August 15, 2006
Radical prostatectomy for high-grade prostate cancerMark D Hurwitz, Delray Schultz, Jerome P Richie, et al.
Cancer|April 27, 2012
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809Mark D Hurwitz, Susan Halabi, Laura Archer, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2010
Radiation therapy induces circulating serum Hsp72 in patients with prostate cancerMark D Hurwitz, Punit Kaur, Ganachari M Nagaraja, et al.
Expert Review of Medical Devices|November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancerNicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Expert Review of Anticancer Therapy|October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysisMark D Hurwitz, Lindsey Schnieder, Judith Manola, et al.
The Medical Journal of Australia|October 22, 2008
A robust clinical review process: the catalyst for clinical governance in an Australian tertiary hospitalImogen A Mitchell, Bobby Antoniou, Judith L Gosper, et al.
International Journal of Radiation Oncology, Biology, Physics|June 13, 2006
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancerClair Beard, Delray Schultz, Marian Loffredo, et al.
Pathology|April 19, 2003
Recent onset granulomatous common variable immunodeficiency in an 88-year-old womanCarolyn A Hawkins, Julie Blasioli, C Siobhan McCarthy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 2, 2015
What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalationNicholas G Zaorsky, Joshua D Palmer, Mark D Hurwitz, et al.
Urology|August 15, 2006
Radical prostatectomy for high-grade prostate cancerMark D Hurwitz, Delray Schultz, Jerome P Richie, et al.
Cancer|April 27, 2012
Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809Mark D Hurwitz, Susan Halabi, Laura Archer, et al.
Pageof 6